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Difficult Mask Ventilation and  
Muscle Paralysis
To the Editor:
We read with great interest the study by Ikeda et al.1 and the 
accompanying editorial.2 It is now increasingly recognized 
that muscle relaxants are beneficial in overcoming difficult 
mask ventilation in adults.2–4 However, both current papers 
are lacking a sufficient discussion of the reasons why mus-
cle relaxation improves difficult mask ventilation. This can 
primarily be deduced from recent pediatric evidence where 
functional airway obstructions are the main reason for dif-
ficult mask ventilation.
Difficult mask ventilation in otherwise normal children is 
exceptionally rare and usually caused by anatomical/mechan-
ical or functional airway obstructions.5 Functional airway 
obstructions (laryngospasm, insufficient depth of anesthe-
sia, opioid-induced muscle rigidity with glottic closure, and 
bronchospasm) are common in children;6 result in significant 
morbidity;7 and require clear concepts and algorithms.8 Early 
muscle relaxation or even “pre-ventilation” muscle paralysis 
will overcome all functional airway problems with the excep-
tion of severe bronchospasm for which systemic epineph-
rine should be immediately available.9 This approach will 
also allow early and less traumatic direct laryngoscopy and 
tracheal intubation, if required urgently, without provoking 
coughing and straining or regurgitation and vomiting.
Amazingly, although muscle paralysis has been shown 
to improve mask ventilation in adults and is increasingly 
becoming a key role in the difficult mask ventilation in chil-
dren with normal airways,9 none of current difficult airway 
algorithms in adults consider functional airway obstructions. 
However, this view is shifting in adults too, as the recently 
published NAP4 report recommends muscle paralysis prior 
to proceeding with an invasive (surgical) airway in the “can-
not intubate - cannot ventilate” scenario or when waking the 
patient up is not an option.10†
Difficult mask ventilation due to functional airway obstruc-
tion with increasing hypoxemia requires muscle paralysis. 
“Cross the Rubicon fast” in patients with a normal airway.
Thomas Engelhardt, M.D., Ph.D.,* Markus Weiss, M.D. 
*Royal Aberdeen Children’s Hospital, Aberdeen, United 
Kingdom. t.engelhardt@nhs.net
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In Reply:
We appreciate the comments of Xue et al., who highlight 
important aspects of our study design,1 which likely influ-
enced the results. We sought to establish a patent, yet less 
than fully dilated upper airway, in order to assess whether 
muscle relaxants dilate or narrow the pharyngeal airways 
of anesthetized subjects. Had the initial airway been fully 
optimized by airway maneuvers, we might have failed to 
observe succinylcholine-induced pharyngeal airway dilation; 
therefore, we chose to maintain a neutral head and mandible 
position in anesthetized normal subjects. Furthermore, the 
tightly fitted facemask and mouthpiece may have further 
narrowed the airway.2 Although the experimental settings 
were different from our usual clinical practice of airway man-
agement, we aimed to test the research hypothesis success-
fully while assuring patient safety. Our experimental design 
limits application of these results to patients with obstructive 
sleep apnea, an independent risk factor for impossible mask 
ventilation.3 In the future, direct assessments of behavior 
of the whole upper airway, including both pharyngeal and 
laryngeal regions, in this patient population will address the 
important questions raised by Xue et al.
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following ill-fated administration of long-acting neuromus-
cular blockade), we rarely see complete inability to exchange 
gas. Because that gas is oxygen, inadequate ventilation but 
sufficient oxygenation typically sustains life long enough to 
resolve the airway crisis, as was observed by Amathieu et al.5 
Of 17 patients experiencing difficult mask ventilation and 
SpO2 less than 80%, all survived without significant com-
plication. How should we respond to other experts’ tena-
cious contention that the “wake up” option is nonviable in 
the face of our successful use of it in practice? “Anecdotal” 
experience is routinely discounted as nonevidence by all but 
those who own it; yet personal observation, reflection, and 
judgment play a much greater role in our clinical work and 
research than we recognize.13 We continue to agree with 
Kopman’s conclusion that “0.6 mg/kg may be a wise choice 
under some conditions,”8 at least preserving the option to 
awaken the patient in an escalating life-threatening difficult 
airway situation.
We also thank Englehardt and Weiss for their excellent 
points, particularly the distinction between mechanical 
and functional obstruction, as occurs not uncommonly in 
pediatric anesthesia practice. We agree with their assertions 
and encourage investigation of the variables contributing to 
functional upper airway obstruction, as well as the decision-
making process for timely interventions that include 
administration of muscle relaxants.
Michael Richardson, M.D., Aya Ikeda, M.D., Shiroh 
Isono, M.D., Ronald S. Litman, D.O.* *University of 
Pennsylvania, Philadelphia, Pennsylvania, and The Chil-
dren’s Hospital of Philadelphia, Philadelphia, Pennsylvania. 
litmanr@email.chop.edu
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We thank Dr. Priebe for his insightful comments. We are 
in agreement that the safety of airway management for the 
vast majority of patients has become nearly perfect, due to 
the high prevalence of sufficiently favorable airways, mod-
ern airway devices, and our well-honed procedural and 
decision-making skills. This is a blessing, but does curse us 
with the challenge of studying this rare but high-stakes prob-
lem, eradication of which still eludes us despite decades of 
research and advances.3–6
While not the main point of our editorial,7 Priebe takes 
strong issue with our practice of ventilation before paralysis 
in selected intermediate-risk patients. Our approach and 
rationale are not unique; it was formally employed in the 
study protocol that Priebe cites—“To reduce the duration 
of apnea, succinylcholine (1 mg/kg) was given when ven-
tilation difficulty was graded III or IV.”5 Changing course 
in response to unexpected challenges during attempts to 
ventilate and administering an appropriate dose of suc-
cinylcholine (we choose 0.6 mg/kg),8 with or without 
the insertion of a supraglottic airway device, most often 
improve or do not worsen ventilation.5 This is not surpris-
ing and is recommended based on newer, more granular 
evidence.6 Additionally, timely muscle relaxation shortens 
the duration of (or eliminates) the struggle to ventilate 
before advancing to definitive management interventions 
(intubation). To be clear, we too have abandoned “the insis-
tence on effective facemask ventilation before administer-
ing muscle relaxant,” but we have not substituted adoption 
of the earliest possible administration of neuromuscular 
blockade in routine practice for every patient. We agree 
that neuromuscular blockers are often part of a solution to 
some airway difficulties. However, we consider the choice 
of a specific muscle relaxant to be an important decision 
point when the planned choice (non-depolarizer) is either 
confirmed or changed in response to what is learned dur-
ing an attempt to mask ventilate. This is reflected in the 
research protocol arm of Amathieu et al.5 So, why not 
administer succinylcholine to all patients, or to all those 
with three or more risk factors? While we have colleagues 
who use succinylcholine very liberally, even routinely, we 
think that its use is often unnecessary and exposes patients 
to risks unique to that drug. Given the unacceptable false-
positive predictive rate around difficult mask ventilation, 
we disagree with routine succinylcholine administration to 
all patients with three or more difficult mask ventilation 
risk factors. Instead, we prefer the approach of administer-
ing succinylcholine when indicated.
Priebe contends that the duration of the effect of suc-
cinylcholine prevents spontaneous ventilation before the 
onset of significant hypoxemia. His supporting quote from 
theoretical work9 omits key underlying assumptions—
a succinylcholine dose of 1 mg/kg and complete apnea. 
Debate over the “wake up” option resurfaced a decade 
ago.8,10–12 In difficult airway situations (including those 
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